Notice Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold

Biotech execs vie for a share of obesity drug boom: ‘It’s the early innings’

A link to the full article by STAT can be found here.